- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Abbott Laboratories
+ Add to WatchlistABL:GR
28.600 EUR 0.200 0.69%As of 10:47:41 ET on 05/17/2013.
Snapshot for Abbott Laboratories (ABL)
| Open: | 28.424 | Day's Range: | 28.424 - 28.765 | Volume: | 584 |
|---|---|---|---|---|---|
| Previous Close: | 28.800 | 52wk Range: | 22.817 - 48.996 | 1-Yr Rtn: | +25.91% |
Key Statistics for ABL
| Current P/E Ratio (ttm) | 8.6344 |
|---|---|
| Estimated P/E(12/2013) | 18.1894 |
| Relative P/E vs. DAX | 0.5308 |
| Earnings Per Share (USD) (ttm) | 4.2496 |
| Est. EPS (USD) (12/2013) | 2.0170 |
| Est. PEG Ratio | 1.5886 |
| Market Cap (M EUR) | 44,583.53 |
| Shares Outstanding (M) | 1,558.87 |
| 30 Day Average Volume | 2,783 |
| Price/Book (mrq) | 2.5322 |
| Price/Sale (ttm) | 1.6196 |
| Dividend Indicated Gross Yield | 1.49% |
| Cash Dividend (USD) | 0.1400 |
| Last Dividend | 04/11/2013 |
| 5 Year Dividend Growth | 2.30% |
| Next Earnings Announcement | 07/18/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for ABL
Company Profile & Key Executives for ABL
Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
| Miles D WhiteChairman/CEO | Thomas C FreymanExec VP:Finance/CFO |
| John M CapekExec VP:Medical Devices | Richard W AshleyExec VP:Corp Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
ABL News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page